ISPE Good Practice Guide: Approaches to Commissioning and Qualification of Ph...

处处学韧

ISPE Good Practice Guide: Approaches to Commissioning and Qualification of Pharmaceutical Water and Steam Systems (Third Edition)[size=0.875]

[size=0.875]Published:September 2025

[size=0.875]Pages:124

处处学韧

• 1 Introduction
• 1.1 Rationale
• 1.2 Historical Context for Validation 4.0
• 1.3 Why Validation Needs to Evolve and What is the Goal
• 1.4 Scope
• 1.5 Structure of this Guide
• 2 Methodology
• 2.1 The Approach – The Foundation
• 2.2 Key Foundational Aspects
• 2.3 Key Guideposts
• 2.4 Combining the Main Concepts into a Holistic Approach
• 2.5 The Validation 4.0 Approach – The Details
• 2.6 The Approach – The Physical Plant
• 2.7 Maturity and its Impact on Validation 4.0
• 3 Enablers and New Capabilities
• 3.1 Computerized Systems Enabling Validation 4.0
• 3.2 Plug and Produce: Data and Systems Integration for Validation 4.0
• 3.3 Cultural Shifts
• 3.4 The Influence of AI Technologies on Validation
• 3.5 Process Analytical Technology (PAT) as an Enabler for Validation 4.0
• 3.6 Digital Twin
• 4 Appendix 1 – AI/ML in Sterile Fill Case Study
• 4.1 Abstract
• 4.2 Objective
• 4.3 The Current Paradigm
• 4.4 Case Study – An Enhanced Control Strategy
• 4.5 Applying Validation 4.0 to the Case Study
• 4.6 Summary of Control Strategy Changes
• 4.7 Control Strategy Perspective
• 4.8 QRM Perspective
• 4.9 Conclusion
• 5 Appendix 2 – Blend Uniformity Case Study
• 5.1 Introduction
• 5.2 Case Study Relevance to Validation 4.0
• 5.3 PAT to Handle Raw Material Variability
• 5.4 Case Study 1: Continuous Control and Verification of Blend Uniformity
• 5.5 Case Study 2: Verification of Blend Uniformity During Manufacturing Scale-up
• 5.6 Conclusion
• 6 Appendix 3 – QbD Case Study
• 6.1 Case Study Setup/Background
• 6.2 Case Study: Overview
• 7 Appendix 4 – Implementing a Digital CPV Tool Case Study
• 7.1 Introduction
• 7.2 What is the Starting Point?
• 7.3 Implementing the Digital CPV Tool
• 8 Appendix 5 – Laboratory Case Study
• 8.1 Challenge and Case Study
• 8.2 Case Study: Overview
• 8.3 Risk Plan and Digital ATP (Analytical Target Profile)
• 8.4 Method Development Steps
• 8.5 Summary
• 9 Appendix 6 – No-Code App Building Platform Case Study
• 9.1 Case Study Setup
• 9.2 Validation Approach
• 9.3 Conclusion
• 10 Appendix 7 – Process Validation Approach for a Personalized Packing Line Case Study
• 10.1 Introduction
• 10.2 Objectives for the Patient-Specific Packing Line
• 10.3 Where is Validation 4.0 Relevant?
• 10.4 Technical Solution and Operation Overview
• 11 Appendix 8 – Automation of Cell Manufacturing Case Study
• 11.1 Introduction
• 11.2 System Overview
• 11.3 Process Control Systems and Data Integration
• 11.4 Manufacturing and Quality Software Connectivity
• 11.5 Incorporating Continuous Verification in Practice
• 11.6 Outcomes and Benefits of Cell Manufacturing Automation Following QbD
• 12 Appendix 9 – The Physical Plant
• 12.1 Holistic Plant View
• 12.2 Holistic Control Strategy is Fed by Complimentary Controls
• 12.3 Breaking it Down Further
• 13 Appendix 10 – Validation 4.0 Maturity Model
• 13.1 Pharma 4.0 Maturity Levels
• 13.2 Pharma 4.0 Elements
• 13.3 The Validation 4.0 Maturity Self-Assessment Tool
• 14 Appendix 11 – References
• 15 Appendix 12 – Glossary
• 15.1 Acronyms and Abbreviations